Skip to content
Excelsior
About Excelsior Medical
Enterprise Spirit
Development Strategy
Related Company
Overseas Business
Company History
Product Description
Hemodialysis / Plasma Exchange
Blood Bag
Artificial Stoma
Health Appliances
ESG
Investors
Enterprise Recruitment
Contact Us
繁體中文
Investors
Investor Zone
Material Information
Board of Directors
Financial Information
Monthly Revenue
Financial Statements
Shareholder Services
Shareholders’ Meeting
Institutional Investor Conference
Dividend
Stock Quotes
Stock Transfer Agent and Registrar
Contacts
Stakeholders
Investor
Material Information
The Company is invited to attend an institutional investor conference hosted by President Securities on November 24, 2025.
2025-11-21
Announcement that the company’s board of directors resolved cash capital increase by issuing common shares
2025-11-07
The Board of Directors release the prohibition on managers from participation in competition businesses.
2025-11-07
Announcement of the resolution by the Board of Directors for the donation to related party.
2025-11-07
The Board of Directors approved Q3 2025 consolidated financial statements.
2025-11-07
Announcement for the expected date of the Board meeting for the Third Quarter of 2025 Financial Report is 2025/11/07
2025-10-30
Announcement of the decision by the Company for the ex-rights record date of stock dividends.
2025-08-22
The Company is invited to attend an institutional investor conference hosted by President Securities on August 22, 2025.
2025-08-21
Announcement of the resolution by the BOD for the ex-rights and record date of stock dividends on behalf of major subsidiary, Excelsior Asset Management Co., Ltd.
2025-08-12
The Board of Directors release the prohibition on managers from participation in competition businesses.
2025-08-12